Vetdox - AQ is an antiprotozoal solution formulated to treat protozoal infections in pets, specifically targeting Babesia gibsoni, toxoplasmosis, and Pneumocystis. With Atovaquone as its active ingredient, Vetdox - AQ effectively disrupts the metabolic processes of the protozoa, halting their growth and spread. This makes it an essential treatment for pets suffering from these parasitic infections. Available in both film-coated tablets and liquid suspension, it ensures versatile administration options for ease of use and effective dosing.
Babesia Gibsoni
Toxoplasmosis
Pneumocystis
13.3-15mg/kg 8hrly for 10 days use doses strictly as per recommended guideline only
Vetdox - AQ is available in two variations—30ml oral suspension and 250mg tablets (10110 pack), as well as a 60ml oral suspension—to provide flexibility in treatment. The oral suspension is ideal for pets that may have difficulty swallowing tablets, ensuring easy administration and precise dosing. The tablets offer a more convenient option for larger pets or those that readily accept tablets, while also providing a cost-effective solution for long-term treatment. With these variations, Vetdox - AQ caters to different pet sizes, preferences, and treatment needs, ensuring optimal care and ease for both pet owners and veterinarians.
Vetdox - AQ contains Atovaquone, which is known for its potent action against protozoal parasites. Atovaquone works by inhibiting mitochondrial respiration in protozoa, specifically targeting the electron transport chain in Babesia and Toxoplasma species. This disruption of energy production prevents the parasites from multiplying, effectively controlling and treating infections like Babesia gibsoni and toxoplasmosis.
In addition to treating Babesia gibsoni, Vetdox - AQ is also effective against other protozoal infections, such as Pneumocystis. The dual action of Atovaquone and its ability to target different protozoal species make it a versatile treatment option for multiple parasitic infections in pets, particularly those with compromised immune systems.
The product is available in two variations: a 250mg tablet for larger pets and a 375mg oral suspension that ensures accurate dosing for smaller or more sensitive animals. This flexible dosing format allows for easy administration and customized treatment, optimizing the efficacy of Atovaquone while ensuring safety for pets of different sizes and needs. The film-coated tablet ensures ease of swallowing, while the oral suspension is designed for pets that may have difficulty with pills.
Q
What is Vetdox-AQ used for in pets?
A
Vetdox-AQ is an antiprotozoal medication used to treat and manage Babesia gibsoni, toxoplasmosis, and Pneumocystis infections in pets. It contains Atovaquone, which effectively targets and kills protozoal parasites by disrupting their cellular processes.
Q
How does Vetdox-AQ work to treat protozoal infections in pets?
A
Vetdox-AQ works by inhibiting mitochondrial respiration in protozoa, particularly the Babesia and Toxoplasma species. This disruption of energy production in the parasites prevents their growth and multiplication, helping to clear the infection from the pet's system.
Q
Is Vetdox-AQ safe for my pet, and how do I administer it?
A
Yes, Vetdox-AQ is safe for pets when administered as directed. It is available in 250mg film-coated tablets and 375mg oral suspension, making it suitable for pets of various sizes. The tablets are easy to swallow, and the suspension is ideal for pets that may have difficulty taking pills, ensuring accurate and comfortable dosing. Always follow the veterinarian’s advice for dosing and duration of treatment.
